Form EFFECT Aegerion Pharmaceuticals
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Aegerion Pharma (AEGR), QLT, Inc. (QLTI) will resume trading at 7:30am ET
June 15, 2016 7:11 AM EDTAegerion Pharma (NASDAQ: AEGR) and QLT, Inc. (NASDAQ: QLTI) will resume trading at 7:30am EDT.
... MoreQLT Inc. (QLTI), Aegerion Pharma (AEGR) Enter Strategic Merger Agreement
June 15, 2016 7:02 AM EDTAegerion Pharmaceuticals, Inc. (Nasdaq: AEGR) and QLT Inc. (Nasdaq: QLTI) announced that they have entered into a definitive merger agreement under which Aegerion will be merged with a wholly owned indirect subsidiary of QLT. Upon completion of the proposed merger, each outstanding share of Aegerion common stock will be exchanged for 1.0256 shares of QLT common stock. QLT plans to change its name upon the closing of the proposed transaction to Novelion Therapeutics Inc. (Novelion) and its common shares will trade on the NASDAQ Global Select Market and the Toronto Stock... More
